The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.00
Bid: 103.00
Ask: 103.40
Change: 1.60 (1.58%)
Spread: 0.40 (0.388%)
Open: 103.60
High: 104.00
Low: 101.80
Prev. Close: 101.40
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IFRS 17 UPDATE

6 Feb 2023 07:00

RNS Number : 9413O
Just Group PLC
06 February 2023
 

 

 

 

 

 

 

NEWS RELEASE

www.justgroupplc.co.uk

6 February 2023

JUST GROUP plc

IFRS 17 UPDATE

 

Just Group plc ("Just", the "Group") has today made presentation slides available on the Group's website www.justgroupplc.co.uk, and provides below an update on its implementation of IFRS 17. IFRS 17 is a new accounting standard for insurers which was implemented on 1 January 2023.

 

We remain committed to our ambition to target 15% growth in underlying operating profit.

Under IFRS 17, we will continue our commitment to deliver 15% growth in underlying operating profit per annum over the medium term. Our IFRS 17 measure for underlying operating profit is explained further below.

Our target to deliver a greater than 10% return on equity will also continue under IFRS 171.

 

No change in strategy, growth ambition, capital, cash or dividend policy.

IFRS 17 is an accounting change and does not affect the underlying economics of our business or our strategy.

· Our commitment and ability to invest in future growth is unchanged

· The capital strength of the Group is unchanged

· Our new and existing business cashflows are unchanged

· The Group's dividend policy is unchanged

· The Group's creditworthiness is unchanged

 

Effect of transition to IFRS 17

Under IFRS 17 total profits remain unchanged. IFRS 17 introduces two new balance sheet concepts - the Contractual Service Margin ("CSM") and Risk Adjustment ("RA"), which are stocks of discounted future value that will be released in accounting terms into reported profit over time. These stocks of future value are added to by future new business, which in turn also release over time.

· We expect the Group's shareholder value to be broadly unchanged as opening IFRS 17 adjusted shareholders equity (IFRS 17 equity and CSM net of tax) on transition at 1 January 2022 is similar to closing IFRS 4 equity of £2.1bn on 31/12/21. This approach reflects the shareholder value created from past business written.

IFRS 17 adjusted shareholders equity is expected to be around £2.1-2.2bn on 1 January 2022 (including CSM net of tax, expected to be c.£0.9-1.1bn).

· Underlying operating profit. To provide a meaningful measure of business performance, we will add back the net change in CSM created during the year to derive underlying operating profit under IFRS 17. We expect this new measure of IFRS 17 underlying operating profit to be comparable to IFRS 4 underlying operating profit.

 

Further Information

Please contact the Investor Relations team, details below.

 

FINANCIAL CALENDAR AND TIMELINES

DATE

BASIS

Results for the year ended 31 December 2022

7 March 2023

IFRS 4

Further updates ahead of interims

June 2023

Including restated comparatives

Interim results for the six months ended 30 June 2023

15 August 2023

First financial reporting under IFRS 17

 

Note 1: Return on equity is IFRS 17 underlying operating profit after attributed tax divided by the average IFRS 17 adjusted shareholders equity less goodwill

Note 2: Alternative performance measure. In addition to statutory IFRS performance measures, the Group has presented a number of non-statutory alternative performance measures within the Annual Report and Accounts. The Board believes that the APMs used give a more representative view of the underlying performance of the Group

Note 3: All the figures are unaudited

 

Enquiries

 

Investors / Analysts

 

Alistair Smith, Investor Relations

Telephone: +44 (0) 1737 232 792

alistair.smith@wearejust.co.uk

 

Paul Kelly, Investor Relations

Telephone: +44 (0) 20 7444 8127

paul.kelly@wearejust.co.uk

 

 

 

 

Media

 

Stephen Lowe, Group Communications Director

Telephone: +44 (0) 1737 827 301

press.office@wearejust.co.uk

 

Temple Bar Advisory

Alex Child-Villiers

William Barker

Telephone: +44 (0) 20 7183 1190

 

A copy of this announcement will be available on the Group's website www.justgroupplc.co.uk

 

JUST GROUP PLC

GROUP COMMUNICATIONS

Enterprise House

Bancroft Road

Reigate

Surrey RH2 7RP

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUPPPUPWGGA
Date   Source Headline
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review
11th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.